Rapport Therapeutics, Inc. RAPP

33.91 0.08 0.24% as of 25 Sep
Market cap
$1.6B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
436.18 476.89 490.64 513.13

+8 more quarters

Receivables
0.29 0.06 — —
Total current assets
446.86 484.70 498.56 520.66
Property, Plant, Equpment (Net)
2.34 2.52 2.98 3.12
Long-term assets (Other)
1.06 1.06 0.99 1.07
Total non-current assets
12.13 12.90 13.87 14.66
Total Assets
458.98 497.60 512.43 535.32
Accounts Payable
2.80 6.56 4.19 3.24
Accrued Expenses
23.16 8.72 12.10 8.60
Total current liabilities
28.42 17.90 19.05 14.32
Total non-current liabilities
7.63 8.19 8.73 9.39
Total liabilities
36.06 26.09 27.78 23.71
Additional Paid In Capital
735.85 727.05 719.29 712.89
Common Stock (Net)
0.05 0.05 0.05 0.05
Retained Earnings
(311.70) (255.08) (235.23) (201.46)
Common Equity (Total)
422.93 471.51 484.65 511.62
Shareholders Equity (Total)
422.93 471.51 484.65 511.62
Shareholders Equity and Liabilities (Total)
458.98 497.60 512.43 535.32
Shares (Common)
47.96 47.81 47.77 47.65
Shareholders Equity (Tangible)
422.93 471.51 484.65 511.62
Net Debt
(436.18) (476.89) (490.64) (513.13)

Fold the line items

In millions of $ except per-share values · columns are period end dates